Effects of β-adrenoceptor antagonists on alcohol drinking by alcohol-dependent rats
Open accessAbstract
Rationale Alcohol-dependent animals display enhanced stress responsivity, reward thresholds, and alcohol self-administration during alcohol withdrawal, and some of these aspects of alcohol dependence may be mediated by activation of brain norepinephrine (NE) systems.Objectives This study examined the effects of propranolol, a β-adrenoceptor antagonist, on operant alcohol-reinforced responding by alcohol-dependent and non-dependent rats.Methods Adult male Wistar rats were trained to respond for alcohol in an operant conditioning paradigm on fixed-ratio-1 (FR-1) and progressive ratio (PR) reinforcement schedules. Rats were either made dependent on alcohol via chronic intermittent (14 h ON/10 h OFF) alcohol vapor inhalation or were not exposed to alcohol vapor. Rats were tested for the effects of propranolol (0-10 mg/kg) or nadolol (0-20 mg/kg) on operant alcohol-reinforced responding at the time point corresponding to 6-8 h withdrawal in dependent animals.Results All doses of propranolol suppressed FR-1 operant alcohol-reinforced responding in alcohol-dependent rats, but only the highest dose suppressed FR-1 responding by controls. No dose of propranolol affected water responding. Nadolol did not affect operant behavior. Propranolol suppressed PR operant alcohol-reinforced responding across groups, an effect attributable to significant suppression of alcohol responding at the highest dose.Conclusions Following development of alcohol dependence, rats exhibit hypersensitivity to the suppressive effects of propranolol on operant alcohol-reinforced responding. This effect is mediated by central actions of the drug, is not attributable to motor effects, and may reflect activation of brain NE systems that contributes to withdrawal-induced negative emotional states and drives alcohol drinking in the dependent organism.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In dependent rats, the alpha1-adrenergic receptor antagonist prazosin selectively blocked the increase in drinking associated with acute withdrawal, and the beta-adrenergic receptor antagonist propranolol blocked the increase in drinking associated with acute withdrawal at doses that did not block nondependent drinking.
“In dependent rats, the a 1 -adrenergic receptor antagonist prazosin selectively blocked the increase in drinking that was associated with acute withdrawal (Walker et al., 2008), and the b-adrenergic receptor antagonist propranolol blocked the increase in drinking that was associated with acute withdrawal in dependent rats at doses that did not block nondependent drinking (Gilpin and Koob, 2010).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Gilpin and Koob, 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Aston-Jones, G., & Cohen, J. D. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135709 · Cited by 4,472 · see citing works
Drug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535 · see citing works
Self-citationA Role for Brain Stress Systems in Addiction
Koob, G. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.012 · Cited by 1,056 · see citing works
Self-citationCorticotropin-releasing factor, norepinephrine, and stress
Koob, G. F. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00164-x · Cited by 629 · see citing works
Self-citationNoradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion
Delfs, J. M., Zhu, Y., Druhan, J. P., & Aston-Jones, G. (2000) · Nature · doi:10.1038/35000212 · Cited by 462 · see citing works
Rassnick, S., Heinrichs, S. C., Britton, K. T., & Koob, G. F. (1993) · Brain Research · doi:10.1016/0006-8993(93)91352-s · Cited by 407 · see citing works
Self-citationValdez, G. R., Roberts, A. J., Chan, K., Davis, H., Brennan, M., Zorrilla, E. P., & Koob, G. F. (2002) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02448.x · Cited by 387 · see citing works
Self-citationFunk, C. K., O'Dell, L. E., Crawford, E. F., & Koob, G. F. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3096-06.2006 · Cited by 381 · see citing works
Self-citationCRF antagonist reverses the “anxiogenic” response to ethanol withdrawal in the rat
Baldwin, H. A., Rassnick, S., Rivier, J., Koob, G. F., & Britton, K. T. (1991) · Psychopharmacology · doi:10.1007/bf02244208 · Cited by 353 · see citing works
Self-citationExcessive Ethanol Drinking Following a History of Dependence Animal Model of Allostasis
Roberts, A. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00167-0 · Cited by 349 · see citing works
Decreased brain reward produced by ethanol withdrawal
Schulteis, G., Markou, A., Cole, M., & Koob, G. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.13.5880 · Cited by 345 · see citing works
Self-citationEnhanced Alcohol Self‐Administration after Intermittent Versus Continuous Alcohol Vapor Exposure
O’Dell, L. E., Roberts, A. J., Smith, R. T., & Koob, G. F. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000145781.11923.4e · Cited by 342 · see citing works
Self-citationNoradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder
Strawn, J. R., & Geracioti, T. D. (2007) · Depression and Anxiety · doi:10.1002/da.20292 · Cited by 314 · see citing works
Sommer, W. H., Rimondini, R., Hansson, A. C., Hipskind, P. A., Gehlert, D. R., Barr, C. S., & Heilig, M. A. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.01.010 · Cited by 309 · see citing works
Clinical Pharmacokinetics of β-Adrenoreceptor Blocking Drugs
Johnsson, G., & Regårdh, C. G. (1976) · Clinical Pharmacokinetics · doi:10.2165/00003088-197601040-00001 · Cited by 294 · see citing works
Funk, C. K., Zorrilla, E. P., Lee, M.-J., Rice, K. C., & Koob, G. F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.063 · Cited by 276 · see citing works
Self-citationCecchi, M., Khoshbouei, H., Javors, M., & Morilak, D. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00062-3 · Cited by 243 · see citing works
Olive, M. F., Koenig, H. N., Nannini, M. A., & Hodge, C. W. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00748-1 · Cited by 237 · see citing works
Smith, R. J., & Aston-Jones, G. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0191-3 · Cited by 206 · see citing works
Walker, B. M., & Koob, G. F. (2006) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00259.x · Cited by 196 · see citing works
Self-citationForray, M. I., & Gysling, K. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.07.011 · Cited by 191 · see citing works
Valdez, G. R., Roberts, A., Chan, K., Davis, H., Brennan, M., Zorrilla, E. P., & Koob, G. F. (2002) · PubMed · doi:10.1097/01.alc.0000033120.51856.f0 · Cited by 187 · see citing works
Self-citationValdez, G. R., Zorrilla, E. P., Roberts, A. J., & Koob, G. F. (2003) · Alcohol · doi:10.1016/s0741-8329(03)00020-x · Cited by 186 · see citing works
Self-citationα1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol
Walker, B. M., Rasmussen, D. D., Raskind, M. A., & Koob, G. F. (2008) · Alcohol · doi:10.1016/j.alcohol.2007.12.002 · Cited by 167 · see citing works
Self-citationA Pilot Trial of the Alpha‐1 Adrenergic Antagonist, Prazosin, for Alcohol Dependence
Simpson, T. L., Saxon, A. J., Meredith, C. W., Malte, C. A., McBride, B., Ferguson, L. C., Gross, C., Hart, K. L., & Raskind, M. A. (2009) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00807.x · Cited by 159 · see citing works
Brain Circuits Involved in Corticotropin‐Releasing Factor‐Norepinephrine Interactions during Stress
DUNN, A. J., SWIERGIEL, A. H., & PALAMARCHOUK, V (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1296.003 · Cited by 155 · see citing works
Randomized Clinical Trial of Atenolol in Patients with Alcohol Withdrawal
Kraus, M. L., Gottlieb, L. D., Horwitz, R. I., & Anscher, M. S. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510103131501 · Cited by 150 · see citing works
Polydipsia Elicited by the Synergistic Action of a Saccharin and Glucose Solution
Valenstein, E. S., Cox, V. C., & Kakolewski, J. W. (1967) · Science · doi:10.1126/science.157.3788.552 · Cited by 148 · see citing works
Cecchi, M., Khoshbouei, H., & Morilak, D. A. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00292-7 · Cited by 147 · see citing works
Operant Behavior and Alcohol Levels in Blood and Brain of Alcohol‐Dependent Rats
Gilpin, N. W., Smith, A. D., Cole, M., Weiss, F., Koob, G. F., & Richardson, H. N. (2009) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.01051.x · Cited by 122 · see citing works
Self-citationβ-adrenergic antagonists attenuate withdrawal anxiety in cocaine-and morphine-dependent rats
Harris, G. C., & Aston‐Jones, G. (1993) · Psychopharmacology · doi:10.1007/bf02244345 · Cited by 118 · see citing works
Curtis, A., Bello, N. T., Connolly, K., & Valentino, R. (2002) · Journal of neuroendocrinology · doi:10.1046/j.1365-2826.2002.00821.x · Cited by 110 · see citing works
Rasmussen, D. D., Alexander, L., Raskind, M. A., & Froehlich, J. C. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00829.x · Cited by 106 · see citing works
Ethanol-Associated Behaviors of Mice Lacking Norepinephrine
Weinshenker, D., Rust, N. C., Miller, N. S., & Palmiter, R. D. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-09-03157.2000 · Cited by 99 · see citing works
Lanteri, C., Salomon, L., Torrens, Y., Glowinski, J., & Tassin, J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301548 · Cited by 95 · see citing works
Dunn, A. J., & Swiergiel, A. H. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.069 · Cited by 94 · see citing works
Comparative efficacy of propranolol and chlordiazepoxide in alcohol withdrawal.
Sellers, E. M., Zilm, D. H., & Degani, N. C. (1977) · Journal of Studies on Alcohol · doi:10.15288/jsa.1977.38.2096 · Cited by 81 · see citing works
INSIGHTS FROM IN VIVO MODIFICATION OF ADRENERGIC RECEPTOR GENE EXPRESSION
Rohrer, D. K., & Kobilka, B. K. (1998) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.351 · Cited by 76 · see citing works
The Psychological Effects of Propranolol in the Abstinence Phase of Chronic Alcoholics
Carlsson, C., & Johansson, T. (1971) · The British Journal of Psychiatry · doi:10.1192/bjp.119.553.605 · Cited by 74 · see citing works
Propranolol Effect on Tremor in Alcoholic Withdrawal
Zilm, D. H. (1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-83-2-234 · Cited by 72 · see citing works
The effects of selective catecholamine depletions by 6-hydroxydopamine on ethanol preference in rats
Brown, Z. W., & Amit, Z. (1977) · Neuroscience Letters · doi:10.1016/0304-3940(77)90109-4 · Cited by 69 · see citing works
Amit, Z., Zw, B., Levitan, D. E., & Ögren, S. O. (1977) · PubMed · Cited by 68 · see citing works
Horwitz, R. I. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.5.1089 · Cited by 68 · see citing works
β-Adrenergic receptors and their interacting proteins
Hall, R. A. (2004) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2003.12.017 · Cited by 67 · see citing works
Rudoy, C., & Bockstaele, E. J. V. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.04.005 · Cited by 58 · see citing works
Koller, W. C., O'Hara, R., Dorus, W., & Bauer, J. (1985) · Neurology · doi:10.1212/wnl.35.11.1660 · Cited by 55 · see citing works
Dependence‐Induced Alcohol Drinking by Alcohol‐Preferring (P) Rats and Outbred Wistar Rats
Gilpin, N. W., Richardson, H. N., Lumeng, L., & Koob, G. F. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00678.x · Cited by 52 · see citing works
Self-citationThe Efficacy of Atenolol in the Outpatient Management of the Alcohol Withdrawal Syndrome
Horwitz, R. I. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390050075015 · Cited by 52 · see citing works
Beta-Adrenergic Antagonists Attenuate Somatic and Aversive Signs of Opiate Withdrawal
Harris, G. C., & Aston‐Jones, G. (1993) · Neuropsychopharmacology · doi:10.1038/npp.1993.66 · Cited by 49 · see citing works
Propranolol and Chlordiazepoxide Effects on Cardiac Arrhythmias During Alcohol Withdrawal
ZILM, D. H., Jacob, M., MacLeod, S. M., Sellers, E. M., & Ti.M.D., T. Y. (1980) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1980.tb04839.x · Cited by 46 · see citing works
Zw, B., Amit, Z., Levitan, D. E., et al. (1977) · PubMed · Cited by 43 · see citing works
Ethanol consumption and reward depend on norepinephrine in the prefrontal cortex
Ventura, R., Carolis, D. D., Alcaro, A., & Puglisi‐Allegra, S. (2006) · Neuroreport · doi:10.1097/01.wnr.0000239964.83566.75 · Cited by 33 · see citing works
Current and Future Status of Beta‐blockers in the Treatment of Hypertension
Chrysant, S. G., Chrysant, G. S., & Dimas, B. (2008) · Clinical Cardiology · doi:10.1002/clc.20249 · Cited by 33 · see citing works
Rudoy, C., Reyes, A.-R. S., & Bockstaele, E. J. V. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.102 · Cited by 31 · see citing works
Reinforcement with intragastric infusions of ethanol: Blocking effect of FLA 57
Davis, W. M., Werner, T. E., & Smith, S. G. (1979) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(79)90038-8 · Cited by 31 · see citing works
Goldberg, S. R., & Gonzalez, F. A. (1976) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30635-x · Cited by 30 · see citing works
Further studies on the role of noradrenergic mechanisms in ethanol withdrawal syndrome in rats.
Trzaskowska, E., & Kostowski, W. (1984) · PubMed · Cited by 20 · see citing works
PROPRANOLOL IN ALCOHOL ADDICTION
Tyrer, P. J. (1972) · The Lancet · doi:10.1016/s0140-6736(72)92110-1 · Cited by 18 · see citing works
Expert Opinion: Beta‐Blockers for Migraine
Evans, R. W., Rizzoli, P. B., Loder, E., & Bana, D. S. (2008) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2007.01046.x · Cited by 15 · see citing works
Qureshi, S. A., & Buttar, H. S. (1989) · Xenobiotica · doi:10.3109/00498258909043148 · Cited by 8 · see citing works
Propranolol and Alcohol Consumption in the Rat
Begleiter, H. (1974) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952997409031911 · Cited by 7 · see citing works
Cardiovascular effects of propranolol in patients with alcohol dependence during withdrawal
Kähkönen, S., Бондаренко, Б. Б., Lipsanen, J. O., et al. (2007) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2007.07.006 · Cited by 4 · see citing works
Korri, U.-M. (1990) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a045045 · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The dark side of emotion: the addiction perspective
Koob, G. F. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.11.044 · Cited by 433 · see citing works
Self-citationDrug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337 · see citing works
Self-citationInfluence of stress associated with chronic alcohol exposure on drinking
Becker, H. C. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.028 · Cited by 191 · see citing works
Operant alcohol self-administration in dependent rats: Focus on the vapor model
Vendruscolo, L. F., & Roberts, A. J. (2014) · Alcohol · doi:10.1016/j.alcohol.2013.08.006 · Cited by 166 · see citing works
Rau, A. R., Chappell, A. M., Butler, T. R., Ariwodola, O. J., & Weiner, J. L. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0384-15.2015 · Cited by 136 · see citing works
Existing and future drugs for the treatment of the dark side of addiction
Koob, G. F., & Mason, B. J. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103143 · Cited by 121 · see citing works
Self-citationDysregulation of brain stress systems mediates compulsive alcohol drinking
Tunstall, B. J., Carmack, S. A., Koob, G. F., & Vendruscolo, L. F. (2017) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2016.10.006 · Cited by 55 · see citing works
Self-citationVanderkam, P., Solinas, M., Ingrand, I., Doux, N., Ebrahimighavam, S., Jaafari, N., & Lafay‐Chebassier, C. (2021) · Addiction · doi:10.1111/add.15265 · Cited by 25 · see citing works
- Authors
- Gilpin, N. W., & Koob, G. F.
- Affiliations
- Scripps Research Institute (US)
- Corresponding author
- Gilpin, Nicholas W.
- Venue
- Psychopharmacology
- Published
- 2010-07-31
- Volume
- 212
- Issue
- 3
- Pages
- 431-439
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- PMC
- PMC2966867
- OpenAlex
- W1983095834
- Cited by
- 99
- References
- 63
- Citations by year
- 2026: 6 · 2025: 3 · 2024: 3 · 2023: 4 · 2022: 9 · 2021: 6 · 2020: 3 · 2019: 7 · 2018: 8 · 2017: 5 · 2016: 9 · 2015: 11 · 2014: 11 · 2013: 5 · 2012: 4
- FWCI
- 1.81
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (R01AA008459, AA012602, AA008459, AA016436, F32AA016436, AA006420, P50AA006420, R37AA008459, R01AA012602, P60AA006420)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- alcoholism, beta-blockers, propranolol, nadolol, alcohol self-administration, alcohol withdrawal, noradrenergic system, progressive ratio schedule, fixed-ratio schedules, alcohol reward
- MeSH terms
- Adrenergic beta-Antagonists, Alcohol Drinking, Ethanol, Alcoholism, Animals, Behavior, Animal, Conditioning, Operant, Dose-Response Relationship, Drug, Male, Nadolol, Norepinephrine, Propranolol, Reinforcement Schedule, Reward, Self Administration, Substance Withdrawal Syndrome, Time Factors, Rats, Wistar, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
